Knock-down of eS6 leads to an upregulation of TOP mRNA translation in primary diffuse large B-cell lymphoma (DLBCL), breast cancer cells (MCF7) and cervical carcinoma cells (HeLa) (34,35). Here, RPS6 is linked to diffuse large B-cell lymphoma.